Sikma

Research Staff Other

Biography

Special interest/expertise                                      

Clinical pharmacology and clinical toxicology in intensive care patients. Maaike works at the intensive care and the Dutch Poisons Information Center of the University Medical Center of Utrecht in The Netherlands. Physiological changes in critically ill patients may have a large effect on pharmacokinetics. For instance, tacrolimus pharmacokinetics may change highly, especially bioavailability extremely varies directly after heart and lung transplantation. Tacrolimus is an immunosuppressant for which correct dosing is important. How to improve tacrolimus dosing in these critically ill patients is still unraveled.

Further, correct antibiotic treatment on the intensive care is of utmost importance. A lot of intensive care patients develop acute kidney injury or augmented renal clearance, which both may have an extreme effect on blood concentrations of e.g., betalactam antibiotics. Improving the intitial antibiotic dose may have a positive effect on outcomes of these vulnerable patients. Enhancing the establishment of renal function is needed to improve correct antibiotic treatment. The measured renal creatinine clearance maybe a practical approach and shows that a large part, approximately 33%, of critically ill patients may have augmented renal clearance. Nevertheless, the unrestraind escalation of antibiotics may lead to overdosing and caution should be taken. Research and training of doctors on these topics are important and often generates new questions and insights that help us further investigate and improve treatment of the critically ill. 

Recent publications

The Right Glucarpidose? Marise R Heerma van Voss, Maaike A Sikma, Frederike K Engels, Anita W Rijneveld, Marieke A Dijkman, Arjen Koppen, Martine E D Chamuleau, Imke H Bartelink
Blood Advances, 2025, vol. 10, p.505–506
Critical care management of the patient with pharmaceutical poisoning Christoph Hüser, Carina Bethlehem, Martin W Dünser, Cornelia Genbrugge, Marc Ghannoum, Lotte C G Hoegberg, Lorenz Van der Linden, Kevin Roedl, Marc Sabbe, Maaike A Sikma, Dominique Vodovar, Bruno Mégarbane,
Intensive Care Medicine, 2025, vol. 51, p.2378-2391
Urine from Intensive Care Patients as a Hotspot for Pharmaceutical Emissions and Sorbent-Based Treatment Bochi Yu, Marko Pranic, Serena Rizzo, Maaike A. Sikma, Alex N.C. Gosselt, Sifra van der Vis, Nora B. Sutton, Gabriel Sigmund
Environmental Science and Technology Letters, 2025, vol. 12, p.862-868
Reply to: 'Methotrexate toxicity and glucarpidase: A call for dose optimization' Arjen Koppen, Maaike A Sikma, Frederike K Engels, Marise R Heerma van Voss, Martine E D Chamuleau, Imke H Bartelink, Marieke A Dijkman
British Journal of Clinical Pharmacology, 2025, vol. 91, p.2764-2766
Methotrexate toxicity and glucarpidase Arjen Koppen, Maaike A. Sikma, Frederike K. Engels, Marise R. Heerma van Voss, Martine E.D. Chamuleau, Imke H. Bartelink, Marieke A. Dijkman
British Journal of Clinical Pharmacology, 2025, vol. 91, p.1289-1292
Failure to reintroduce home medication in critically ill patients Florens N. Polderman, Hieronymus J. Derijks, Maaike A. Sikma, Rob J. van Marum
Journal of Critical Care, 2025, vol. 88